Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine
about
A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderlyClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetInnervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestine.Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.Lubiprostone in constipation: clinical evidence and place in therapy.A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.β-Nicotinamide adenine dinucleotide acts at prejunctional adenosine A1 receptors to suppress inhibitory musculomotor neurotransmission in guinea pig colon and human jejunum.Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig.Translational neuropharmacology: the use of human isolated gastrointestinal tissues.Mast cell expression of the serotonin1A receptor in guinea pig and human intestinePhysiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractilityLubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-mediated PathwayLong-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain.GRG Profiles: Jackie D. Wood.Enteric Nervous System: Neuropathic Gastrointestinal Motility.Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon.
P2860
Q26824999-61427586-601E-41C7-9F2C-510D9439A85EQ26995944-C5DEEE8C-FCA8-4E7B-941C-6DBA5C218C41Q28066092-D1D30EAB-5792-4076-8BEA-365D0367F12AQ34295415-21DAF06D-04E3-43F2-A56C-49B244EBA293Q34552212-9C3E038A-14D6-4D32-9A1E-7F24B3C605B3Q35091370-553035EF-8B30-42DB-8512-B181AEF086D4Q35583262-CC562BFB-3704-4988-AD2E-1AFD7B060A90Q35671813-3BF141F4-F044-4EBE-BF0C-DF83577788DEQ36065514-D2C7E470-653E-4622-BD44-343B6994844AQ36603175-B9589547-D718-4F01-B260-1796E4862282Q36837914-76C55EE8-EC57-48F3-A321-01805467B112Q37491434-F8EB9A71-F8F6-4580-B2A5-8C6FF43A89C3Q37869371-C73B62D1-FCB4-46F2-9196-F1CFA76F4F52Q39175158-B8DB1ED8-7527-4F57-8860-9EE16D1712A9Q41669264-5A28C0A9-65F7-4B94-B16B-13D2AEC755BCQ41784614-1DC79AA4-9914-4DA0-BEC5-93D605D537A8Q44331744-B30912F7-F40F-4863-B703-2D9D9C368896Q48519731-6ACC7888-0F08-4C2E-A54C-2D2F14A031FAQ53108964-D547BF5F-F4A8-471E-B972-0DC9C3D21F53Q53263085-AAE2BA79-DD0C-4EEF-94D9-D24B8E427A7E
P2860
Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Lubiprostone reverses the inhi ...... etion in human small intestine
@ast
Lubiprostone reverses the inhi ...... etion in human small intestine
@en
type
label
Lubiprostone reverses the inhi ...... etion in human small intestine
@ast
Lubiprostone reverses the inhi ...... etion in human small intestine
@en
prefLabel
Lubiprostone reverses the inhi ...... etion in human small intestine
@ast
Lubiprostone reverses the inhi ...... etion in human small intestine
@en
P2093
P2860
P50
P1476
Lubiprostone reverses the inhi ...... etion in human small intestine
@en
P2093
Dean J Mikami
Guo-Du Wang
Ryuji Ueno
W Scott Melvin
Xiaohong Sun
P2860
P2888
P304
P356
10.1007/S10620-010-1515-8
P577
2010-12-23T00:00:00Z